| Trial ID: | L0155 |
| Source ID: | NCT01807910
|
| Associated Drug: |
Methyl-09-choline
|
| Title: |
ER Stress in NAFLD
|
| Acronym: |
--
|
| Status: |
Withdrawn
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Obesity|NAFLD
|
| Interventions: |
Drug: methyl-D9-choline
|
| Outcome Measures: |
Net hepatic phospholipid production|Kinetics of secretory lipoprotein phospholipids
|
| Sponsor/Collaborators: |
Vanderbilt University
|
| Gender: |
Female
|
| Age: |
30 Years to 60 Years ?? (Adult)
|
| Phases: |
Early Phase 1
|
| Enrollment: |
0
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science
|
| Start Date: |
October 2013
|
| Completion Date: |
April 2018
|
| Results First Posted: |
--
|
| Last Update Posted: |
October 23, 2013
|
| Locations: |
Vanderbilt University Medical Center, Nashville, Tennessee, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT01807910
|
